Source comparison
Comparison Table: Hormone Secretagogue Pathways
GHRH (e.g., CJC-1295) Binds to GHRH receptors, stimulates pituitary GH release. None. Does not aromatize. Negligible to None. Virtually Zero. AAS (e.g., Testosterone) Binds to androgen receptors, promotes anabolism. Yes (if aromatizable). Generally low, but ca
This comparison does not assign a generated winner or score.
- GHRH (e.g., CJC-1295)
- Binds to GHRH receptors, stimulates pituitary GH release.
- None. Does not aromatize.
- Negligible to None.
- Virtually Zero.
- AAS (e.g., Testosterone)
- Binds to androgen receptors, promotes anabolism.
- Yes (if aromatizable).
- Generally low, but can be affected by estrogen.
- High (from estrogen conversion).
- Selective GHRP (e.g., Ipamorelin)
- Binds to ghrelin receptors, stimulates pituitary GH release.
- Very Low to None.
- Extremely Low.
- Older GHRP (e.g., GHRP-2/6)
- Mild to Moderate (transient).
- Very Low (prolactin pathway only).
- As you can see, the risk profile is dramatically different. The pathway simply isn't there for a compound like CJC-1295.